Berdyshev EV, Lungarella G, Tuder RM. Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide.
matrix proteolysis, and alveolar cell apoptosis has been postulated to cause alveolar destruction in emphysema (7, 11, 40, 41) . Understanding the molecular basis of their interaction may help to better clarify the unique characteristics of this disease, since similar mechanisms operate in other lung pathological processes, such as acute lung injury or pneumonia, which are not characterized by emphysematous lung destruction.
Oxidative stress, caused by cigarette smoke itself, or by infiltrating inflammatory or injured parenchymal cells, may act as a critical mechanism that links inflammation, excessive matrix proteolysis, and alveolar cell apoptosis. A central role for oxidative stress in emphysema development and pathophysiology has been supported by the documentation of oxidative stress in lungs, bronchoalveolar lavage, and peripheral blood mononuclear cells of COPD patients and in smokers (8, 10, 30, 32, 45) . Recent reports confirm the contribution of oxidative stress to emphysema pathophysiology by an observed increase in susceptibility of mice lacking the critical antioxidant transcription factor, nuclear erythroid-related factor-2 (Nrf-2), to cigarette smoke-induced emphysema when compared with wild-type littermates (34) .
Although definitive data examining the beneficial effects of antioxidant supplementation in COPD patients have yet to be described, recent reports demonstrate protection against alveolar oxidative stress, alveolar cell apoptosis, and alveolar enlargement by a small molecule superoxide dismutase (SOD) mimetic in the rat model based on VEGF receptor blockade (42) , as well as reported protection of Cu/Zn SOD overexpressing mice against alveolar destruction caused by chronic cigarette smoke exposure (12) . These studies, together with recent work identifying a key role for ceramides in emphysema-like lung injury (28) , led us to investigate whether ceramides and oxidative stress engage each other into stimulatory feedback signaling in the injured lung.
Ceramides are signaling sphingolipids composed of a sphingoid base and a fatty acid side chain that may vary in length and saturation, defining the various ceramide species. The ceramide-initiated signaling activates various stress-response, apoptosis, and cell senescence pathways (15) . In turn, the enzymatic regulation of ceramide synthesis occurs via sphingomyelin hydrolysis by neutral or acid sphingomyelinase, via de novo pathway synthesis involving serine palmitoyl-CoA transferase, and to some extent via catabolism. At the cellular level, ceramide accumulation is induced by environmental or oxidative stress, cytokines, or LPS (29) . In most models, including cultured pulmonary cells and in the VEGF receptor blockade model of emphysema, ceramides act upstream in the apoptosis process, preceding caspase-3 activation (28, 35, 37, 39) . Although several studies have evaluated specific lung effects due to elevated ceramide levels, the distinct mechanisms underlying these effects remain largely undefined. Acutely, within minutes, ceramides increase vascular permeability (13, 36) , whereas more delayed effects include apoptosis and alveolar enlargement (28) . Findings in cell culture systems where ceramides induced reactive oxygen species (ROS) directly by altering mitochondrial function (2, 31) or indirectly by inactivating antioxidant enzymes such as catalase (16) indicate a potentially complex cross talk between ceramides and oxidative stress in vivo in the lung.
To study these interactions, we modeled lung ceramide increases by directly instilling ceramides intratracheally into the lungs of mice. We have previously demonstrated that direct delivery of ceramide to the lungs increased endogenous ceramides up to twofold, to a range comparable to concentrations seen in human lungs of smoking-induced emphysema (27, 28) and sufficient to trigger both alveolar epithelial and endothelial cell apoptosis and expression of oxidative stress biomarkers such as 8-hydroxyguanosine (28) . In this report, using transgenic overexpression of the antioxidant enzyme Cu/Zn SOD and apoptosis inhibitors, we identified that ceramide induces redox-dependent cell death and alveolar enlargement. (Cer8:0  ceramide) , N-lauroyl-D-erythro-sphingosine (Cer12:0 ceramide), and N-octanoyl-D-erythro-sphinganine (C8:0 dihydroceramide) were from Avanti Polar Lipids (Alabaster, AL). Primary antibodies utilized were actin (Calbiochem, LaJolla, CA), active caspase-3/7 (Cell Signaling Technology, Beverly, MA and Abcam, Cambridge, MA), ASMase (Santa Cruz Biotechnology, Santa Cruz, CA), Cu/Zn SOD (Upstate, Lake Placid, NY), GAPDH (Abcam), and vinculin (Calbiochem). All other reagents were from Sigma-Aldrich (St. Louis, MO) unless otherwise specified.
MATERIALS AND METHODS

Chemicals and reagents. N-octanoyl-D-erythro-sphingosine
Animal studies were approved by the Animal Care and Use Committee of Johns Hopkins University and Indiana University. A transgenic breeding pair of a wild-type C57/Bl6 mouse and a C57/Bl6 mouse overexpressing human Cu/Zn SOD were procured from the Jackson Laboratory (stock #002629). The entire human SOD1 sequence was used for the transgene. Seven copies of the transgene were inserted into chromosome 3 (J:18645). Mice were bred in our American Association for Accreditation of Laboratory Animal Care-accredited animal facility. At 4 wk of age, animals were tagged and tails clipped. DNA from their tail biopsies was isolated for genotyping. Protocols for both mouse tail DNA isolation and genotyping by PCR were provided by Jackson Laboratory. Transgenic animals were identified by the presence of the human Cu/Zn SOD transcript, whereas IL-2 was used as internal wild-type control ( Supplementary  Fig. 1B . Supplemental data for this article is available online at the AJP-Lung web site.). Experiments such as ceramide administration were performed on male and female mice at 3-4 mo of age.
Cigarette smoke exposure was performed as previously described (6) . DBA2 mice (n ϭ 5 per group) were exposed to cigarette smoke or ambient air for 4 wk. Mice were then euthanized, lungs were dissected, and the lung tissue was snap-frozen and stored. The lipid extraction was performed by a Bligh and Dyer method, and lipid phosphorus was measured as described (28) . Ceramides were measured by tandem mass spectroscopy utilizing internal standards C17 (28) and normalized by lipid phosphorus concentration. This method enables one to both measure individual ceramide species and discriminate between ceramides and dihydroceramides, the immediate precursors of ceramide in the de novo pathway of its synthesis.
Ceramide administration was performed as previously described (28) . Briefly, bioactive ceramide or dihydroceramide was first solubilized in ethanol and then delivered with perfluorocarbon as vehicle. We performed experimental instillation of ceramide or dihydroceramide (1 mg/kg it) in transgenic mice (3-6/group) and wild-type littermate control mice at 3 mo of age for both females and males. A separate experiment was performed comparing ceramide or vehicle (perfluorocarbon) in transgenic mice (5-8/group) and wild-type littermate control mice at 3 mo of age for both females and males. We performed intratracheal instillation by two techniques, under indirect and direct visualization of the trachea. We have previously documented the efficiency of ceramide delivery with the less invasive, indirect technique, also known as aspiration (20) , which generated a similar degree of air space enlargement and apoptosis as the direct approach (28) . Given that excessive apoptosis may generate further oxidative stress (42), we dissected the role of caspase-dependent apoptosis on the ceramide-induced oxidative stress. For caspase inhibition in vivo, mice were given a general caspase inhibitor, Z-Asp-CH2-DCB (3 mg/kg; Biomol International, Plymouth Meeting, PA), successfully used in vivo to inhibit lung apoptosis and to attenuate ceramide-induced air space enlargement (18, 28) , or DMSO (vehicle) intraperitoneally daily 2ϫ (on day 1, the inhibitor was injected 60 min before ceramide instillation). At the end of experiments, the mice were euthanized, and the tissue was processed as described. In addition, mice underwent bronchoalveolar lavage (BAL) with 0.6 ml of PBS times 3. The whole BAL was then snap-frozen in liquid nitrogen and stored at Ϫ80°C for further analysis. An aliquot was used for cell counting.
Lipid extraction and ceramide species measurement by tandem mass spectroscopy. To determine which ceramide molecular species were present in lung samples from cigarette smoke, we used a modification of the combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) technique by Sullards and Merrill (38) . Cellular or lung tissue lipids were extracted, and lipid content was assessed by measurements of total lipid phosphorus (P i) (28) . After lipid extraction, ceramides were eluted as previously described (28) . The following individual molecular species of ceramides were monitored: 14:0, 16:0, 18:0, 18:1, 20:0, 24:0, and 24:1-ceramides, utilizing C17 ceramide as internal standard.
Measurements of oxidative stress included detection of nitrotyrosine (42), lipid peroxides, superoxide, and hydrogen peroxide, as well as lung enzymatic activity of superoxide dismutase and catalase. Nitrotyrosine expression was evaluated by immunohistochemistry (IHC) of lung parenchyma (large airways and large blood vessels were omitted). Briefly, 5-m paraffin slides were incubated with anti-nitrotyrosine antibody (dilution 4:1,000; Zymed, South San Francisco, CA). Slides were then coded, and a blinded individual captured random pictures of the stained slides. Intensity of staining was quantified via image analysis software (Metamorph; Molecular Devices, Downingtown, PA), and an index was calculated from the total pixel count generated. Lipid peroxides were measured in lung lysates using the LPO kit from Cayman Chemical (Ann Arbor, MI). The superoxide levels and SOD activity were measured using kits from Calbiochem and Cayman Chemical, respectively. Superoxide levels were measured in BAL (10 l) previously snap-frozen via luminolbased chemiluminescence, and results were expressed as relative light units normalized by the number of cells in the BAL. To ensure the specificity of the superoxide detection assay, we used as positive and negative controls the xanthine and xanthine oxidase reaction (25 M), which generate superoxide anions that oxidize luminol and the neu-tralization of this reaction with SOD (25 units), respectively. The specificity of the assay for superoxide anion was confirmed by complete neutralization of the luminescence signal generated by the xanthine and xanthine oxidase reaction (447.9 RLU) by the SOD enzyme (200 RLU). The superoxide dismutase activity was measured in total lung lysates and in lysates that were fractionated into cytosolic and mitochondrial components by centrifugation at 10,000 g for 15 min at 4°C (24) . The hydrogen peroxide was measured by the Fluoro H 2O2 kit from Cell Technology (Mountain View, CA) utilizing aliquots of previously snap-frozen BAL. The catalase activity was measured in lung tissue lysates utilizing the Amplex Red Catalase Assay Kit from Molecular Probes (Eugene, OR) following the manufacturer's instructions.
Morphometric analysis was performed on coded slides as described (1, 42) .
Apoptosis was detected in lysates (28) or inflated lung enabling focus on alveoli, rather than large airways and vessels (42) via active caspase-3 IHC (Abcam and Cell Signaling) or in situ labeling of apoptotic DNA on murine lung (28), using rat serum as negative control. The immunostaining for both casapase-3 and TUNEL was followed by DAPI (Molecular Probes) nuclear counterstaining. Executioner caspase (caspase-3 and/or -7) activity was measured with ApoONE Homogeneous Caspase-3/7 assay kit (Promega, Madison, WI) as described (28) . Human recombinant caspase-3 (Calbiochem) was utilized as positive control.
Acid sphingomyelinase enzymatic activity determination. The acid sphingomyelinase activity was measured at pH 5.0 in the absence of added cations as described (28) utilizing the Amplex E Red Sphingomyelinase Assay Kit (Molecular Probes) following the manufacturer's instructions. Results were normalized by the protein content of the lung lysate.
Western blotting. Lung tissue was homogenized in RIPA buffer with protease inhibitors on ice, and proteins were isolated by centrifugation at 10,000 g for 10 min at 4°C. Proteins were loaded in equal amounts (10 g, unless otherwise noted) as determined by BCA protein concentration assay (Pierce, Rockford, IL). Total proteins (10 -50 g/lane) were separated by SDS-PAGE using Novex gels (Invitrogen, Carlsbad, CA), followed by immunoblotting for human Cu/Zn SOD as previously described (28) . The chemiluminescent signals were quantified by densitometry (ImageQuant; Amersham, Piscataway, NJ) and normalized by housekeeping proteins (actin, GAPDH, or vinculin).
Zymography. Lung tissues were homogenized in homogenization buffer (50 mM Tris ⅐ HCl, pH 7.6, 150 mM NaCl, 5 mM CaCl 2, 1% Triton X-100, 0.05% Brij-35) with protease inhibitors (2.3 mM AEBSF, 30 M pepstatin, 1 g/ml leupeptin, and 1 g/ml aprotinin). Homogenates were sonicated using a cell disrupter, and supernatants collected after centrifugation at 10,000 rpm at 4°C. Total protein concentrations were determined by BCA assay. Homogenates (30 g) were mixed with nondenaturing 5ϫ Laemmli buffer (0.125 M Tris ⅐ HCl, pH 6.8, 20% glycerol, 4% SDS, 0.004% bromophenol blue) and resolved on either 10% or 12% gelatin-containing polyacrylamide gels (Bio-Rad). Gels were incubated at room temperature in 50 mM Tris ⅐ HCl, pH 7.6, 5 mM CaCl 2, 1 M ZnSO4, 2.5% Triton X-100 for 25 min, and then washed in 50 mM Tris ⅐ HCl, pH 7.6, 5 mM CaCl2, and 1 M ZnSO4. Gels were stained with coomassie blue for 60 min and then destained for detection of MMP activity, which was quantified by densitometry using Image J (NIH) software.
Statistical analysis was performed with SigmaStat software using ANOVA with Student-Newman-Keuls post hoc test. Statistical difference was accepted at P Ͻ 0.05.
RESULTS
Augmentation of ceramide levels in the lung triggered oxidative stress. We have previously shown that intratracheal administration of bioactive synthetic ceramide 12:0 (Cer 12:0 ) Fig. 1 . Effect of ceramide on oxidative stress in the mouse lung and modulation by Cu/Zn SOD overexpression. A: nitrotyrosine expression levels detected by immunohistochemistry (IHC) in the lung parenchyma 48 h after intratracheal administration of vehicle (n ϭ 5) or ceramide 12:0 (Cer; 1 mg/kg; n ϭ 5). Paraffin sections from lungs of mice were coded, and images of alveolar tissue were captured in a random blinded fashion. The number of alveolar cells expressing nitrotyrosine and the expression intensity were quantified by image software analysis and expressed as index (means ϩ SD; *P ϭ 0.002, ANOVA). B: lipid peroxide levels measured in the lungs of wild-type (WT; n ϭ 4) or Cu/Zn SOD transgenic (Tg; n ϭ 5) mice 48 h after Cer instillation compared with control (means ϩ SE; *P ϭ 0.050 vs. control). C: superoxide levels in bronchoalveolar (BAL) lavage of WT (n ϭ 4) and Tg (n ϭ 6) mice 48 h after intratracheal Cer instillation (means ϩ SE; *P ϭ 0.01 vs. WT Cer).
augments endogenous ceramide levels in a dose-dependent manner (28) . A dose of 1 mg/kg resulted in a twofold increase in endogenous lung ceramides and raised the absolute ceramide content to levels comparable to those measured in samples from patients with cigarette smoke-induced emphysema and in emphysematous lungs of mice and rats treated with a VEGF receptor blocker (28) . Furthermore, this approach increased 8-hydroxyguanosines detected at 24 h postinstillation, suggesting oxidative damage of nucleic acids in the lung parenchyma (28) . We therefore utilized this dose of exogenous ceramide delivered intratracheally to adult mice to further define the selective effect of augmented lung ceramides on the redox state of the lung. Ceramide instillation markedly increased other markers of oxidative damage such as lung nitrotyrosine expression (Fig. 1A) and lung lipid peroxide levels (Fig. 1B) . In accordance to alterations seen in COPD patients (33) and rodent models of the disease (34), ceramide treatment was associated with elevation of ROS in the BAL of mice compared with control animals. The average cell number in the BAL in all treatment groups was 17 ϫ 10 4 /ml, with a majority of alveolar macrophages (Ͼ90%). There was no significant loss of cell viability in the BAL of ceramide-instilled lungs, as assessed by trypan blue staining. Although difficult to measure due to their instability, ceramide treatment was associated with a trend of increased hydrogen peroxide (Supplementary Fig.  1A ) and superoxide (Fig. 1C ) levels in the lavage of mice at 48 h.
Ceramide treatment inhibited lung SOD activity. Interestingly, the cytosolic rather than the mitochondrial SOD activity was markedly decreased by ceramide instillation compared with control (Fig. 2, A and B) . In addition, a trend towards a decrease in lung catalase activity following ceramide treatment was observed (Fig. 2C) . The primary destructive effect of ceramide augmentation in the lung parenchyma appears to be alveolar cell apoptosis (28) , which may itself trigger further oxidative stress and disrupt mitochondrial protein, such as mitochondrial SOD (42) . To determine whether the effect of ceramide on antioxidant enzymes was apoptosis dependent, we treated mice with a general caspase inhibitor. We have previously demonstrated that caspase inhibition by an identical approach was effective in this model in decreasing ceramideinduced apoptosis (28) . However, attenuating caspase activation had no statistically significantly effect on the ceramideinduced modifications of cytosolic SOD (Fig. 2A) or catalase (Fig. 2C) activities. On the other hand, caspase inhibition augmented mitochondrial SOD activity (Fig. 2C) , suggesting a cross talk between caspase and mitochondrial SOD antioxidant activities or mitochondrial integrity. The finding that ceramides decreased cytosolic SOD activity and increased superoxide production in the lungs of mice prompted us to investigate the effects of Cu/Zn SOD activity augmentation on the ceramideinduced redox state of the lung.
Cu/Zn SOD overexpression prevented ceramide-induced lung oxidative stress. As expected (43) , transgenic mice overexpressing human Cu/Zn SOD, demonstrated by genotyping and protein analysis ( Supplementary Fig. 1B and Fig. 3A , respectively), exhibited marked increases in lung SOD activity compared with wild-type littermates (Fig. 3B) . In this setting of augmented SOD, lung ceramide augmentation failed to inhibit SOD activity (Fig. 3B) . The Cu/Zn SOD transgenic overexpression was associated with significant protection against ceramide-induced oxidative stress in the lung (Figs. 1, B and C, and Supplementary Fig. 1A) .
Cu/Zn SOD overexpression attenuated ceramide-induced caspase-3 activation in the lung. We have previously demonstrated that intratracheal ceramide instillation induced lung Fig. 2 . Antioxidant enzymatic activities in response to ceramide augmentation in the lung and modulation by caspase inhibitors. Lung SOD activity levels measured 24 h after intratracheal dihydroceramide (control; white bar) or ceramide (Cer) instillation (1 mg/kg) without (black bar) or with Z-Asp-CH2-DCB (3 mg/kg ip daily ϫ2; gray bar). SOD activity was measured in lung lysates after fractionation into cytosolic (A) and mitochondrial components (B), respectively, followed by normalization by protein concentration (means ϩ SE; *P Ͻ 0.05 vs. control). C: catalase activity levels in the mouse lung measured 24 h after intratracheal dihydroceramide (control; n ϭ 3) or ceramide (Cer; n ϭ 4) instillation (1 mg/kg) without (black bar) or with Z-Asp-CH2-DCB (3 mg/kg ip daily ϫ2; gray bar). Results were expressed as mean fold change compared with control (dotted line) ϩSE. alveolar cell apoptosis, characterized by caspase-3 activation, elevated TUNEL-positive cells, and bax activation (28) . Therefore, in this study, we chose the caspase-3 activity as the endpoint marker for apoptosis of lung parenchyma. This endpoint allows for both quantitative assessment and localization studies of cellular apoptosis to alveolar spaces rather than large airways or vessels. In line with our previous results, ceramide treatment significantly enhanced caspase-3 activation in lungs of wild-type littermates of transgenic mice compared with vehicle control (Fig. 4, A and B) . The extent of ceramideinduced alveolar cell apoptosis was markedly attenuated in the Cu/Zn SOD transgenic mice (Fig. 4, A and B) . Furthermore, the Cu/Zn SOD overexpressing mice manifested a reduction in the baseline caspase-3 activity measured in vehicle-treated animals (Fig. 4, A and B) . To ascertain whether the increase in caspase-3 activity occurred in alveolar septal cells, alveolar cell apoptosis was determined by immunohistochemical detection of active caspase-3. Indeed, alveolar cells of wild-type mice treated with ceramide exhibited elevated active caspase-3 compared with vehicle-treated wild-type mice, whereas Cu/Zn SOD mice exhibited reduced levels of alveolar cell apoptosis in response to ceramide instillation (Fig. 4, C and D) .
Ceramide-induced air space enlargement was inhibited in Cu/Zn SOD transgenic mice. Mice overexpressing Cu/Zn SOD were protected against ceramide-induced air space enlargement at 48 h (Fig. 5, A and B) . We have shown previously (28) that ceramide instillation in the lung increases alveolar mean linear intercept associated with an activation of matrix proteases such as MMP-12 at 24 h. In addition, MMP-9 activity was significantly increased in the lungs of mice 48 h following ceramide instillation ( Supplementary Fig. 2 ). Ceramide treatment increased the mean linear intercept from 50.4 Ϯ 1.1 m (mean Ϯ SE) in controls to 54.5 Ϯ 1 in wild-type mice, but only to 52.4 Ϯ 0.9 in Cu/Zn SOD transgenic mice (P ϭ 0.012 by 2-way ANOVA with post hoc Bonferroni t-test) showing a statistically significant increase in alveolar diameters after ceramide administration in wild-type (P ϭ 0.015), but not in transgenic mice (P ϭ 0.255). The significant protection conferred by the overexpression of Cu/Zn SOD against ceramideinduced lung apoptosis and air space enlargement suggested that ROS generated by ceramides in the lung directly contributed to alveolar enlargement.
Exogenous ceramides fail to activate acid sphingomyelinase in the Cu/Zn SOD transgenic lungs. We have shown that ceramides administered intratracheally to mice (with a fatty acid chain of 12 carbons) caused an increase in endogenous ceramides (with fatty acid chains of 14 carbons and higher) concomitant with ASMase activation (28) . We postulated that the ASMase activation generates more ceramides, thus leading to a positive feedback mechanism causing the amplification of lung injury (illustrated in schematic in Supplementary Fig. 3 ). To investigate whether the protective action of Cu/Zn SOD overexpression was associated with an inability of exogenous ceramides to amplify further ceramide synthesis, we measured the ASMase activity in the lungs of wild-type and Cu/Zn SOD transgenic animals 48 h following intratracheal exogenous ceramide 12:0 or vehicle administration. Unlike wild-type mice, which manifested a 50% increase in ASMase activity, the Cu/Zn SOD overexpressing mice failed to increase the lung ASMase activity in response to exogenous ceramide (Fig. 6) .
Cigarette smoke exposure increases ceramides in the lung. Cigarette smoke is the most common etiological insult in emphysema, and Cu/Zn SOD overexpression has been shown to attenuate both the oxidative stress and alveolar enlargement from chronic cigarette smoke exposure in mice (12) . Since our data implicated ceramides in the upregulation of oxidative stress in the lung, which was prevented by Cu/Zn SOD overexpression, we asked whether ceramides are upregulated in vivo by cigarette smoke. Cigarette smoke has been shown to upregulate ceramide levels in lung endothelial cells (28) . Furthermore, ceramides were elevated in a model of apoptosisdependent emphysema, induced by VEGF receptor blockade in mice and rats (28) . However, the contribution of cigarette smoke to the upregulation of endogenous ceramides in vivo remains undefined. We measured ceramides by tandem mass spectroscopy in the lungs of mice exposed to cigarette smoke extract for 4 wk. Cigarette smoke exposure significantly upregulated lung ceramides compared with control lungs, increasing the ceramide concentration per unit of phospholipids by 26% (P ϭ 0.01) (Fig. 7A) . Interestingly, dihydroceramides were also increased by cigarette smoke (by 37%) (Fig. 7B) , suggesting activation of the de novo pathway of ceramide synthesis as a potential mechanism of initial ceramide upregulation. (lanes 1-4) and transgenic (Tg) mice (lanes 5-10) detected by Western blot with species-specific Cu/Zn SOD antibody. B: SOD activity levels in the lungs of WT and Cu/Zn SOD transgenic mice measured 48 h after intratracheal vehicle (Veh) or ceramide (Cer) instillation. SOD activity was measured in lung lysates and normalized by protein concentration (means ϩ SD; *P ϭ 0.03 vs. Veh-Wt; **P Ͻ 0.05 vs. WT). Number of animals studied: WT ϩ Veh, n ϭ 5; WT ϩ Cer, n ϭ 4; Tg ϩ Veh, n ϭ 5; Tg ϩ Cer, n ϭ 8. Fig. 4 . Effect of Cu/Zn SOD transgenic overexpression on ceramide-triggered caspase-3 activation in the mouse lung. A: kinetics of caspase-3 activity in mouse lung lysates incubated with a fluorescently labeled specific caspase substrate. Results were expressed in units of activity of recombinant human caspase-3, normalized by protein concentration; means Ϯ SD. B: boxplot of caspase-3 activities measured in lung lysates from wild-type (WT) and Cu/Zn SOD transgenic (Tg) mice after vehicle (light boxes) or ceramide (Cer; dark boxes; n ϭ 7) instillation. Horizontal line represents median activity normalized by protein concentration, with dots showing outliers and whiskers showing the 5th and 95th percentile values, respectively. (ANOVA followed by Bonferroni t-test; *P Ͻ 0.05 vs. Veh-Wt; **P Ͻ 0.05 vs. Cer-Wt). C: expression levels of active caspase-3 (brown, arrows) detected by IHC with specific active caspase-3 antibody in the lung parenchyma of wild-type and Cu/Zn SOD transgenic (Tg) mice 48 h after intratracheal instillation of vehicle or ceramide (1 mg/kg). D: quantification of caspase-3 immunostaining. Random sections were imaged from coded slides, followed by computation of the intensity and areas of caspase-3 activation by image analysis software, normalized by total nuclei (DAPI-stained; means ϩ SE, *P Ͻ 0.05 compared with Cer-Wt. Ctl represented Veh-treated lungs). Number of animals studied: Wt ϩ Veh, n ϭ 5; Wt ϩ Cer, n ϭ 4; Tg ϩ Veh, n ϭ 5; Tg ϩ Cer, n ϭ 8.
DISCUSSION
The present study shows that selective increases in lung ceramides by airway instillation of bioactive synthetic ceramides inhibited SOD activity, subsequently causing increased oxidative stress in the lung. In turn, the oxidative stress directly contributed to caspase activation and alveolar space enlargement as documented by the protective effects of overexpressing Cu/Zn SOD in mice. In follow-up of our initial observation that ceramide induces the activation of ASMase (28), an enzyme responsible for further increases in endogenous ceramides, we documented in the current study that the lung ASMase activation is redox dependent. Overall, these results for the first time directly implicate oxidative stress as a downstream pathological mediator of alveolar enlargement caused by increased lung ceramides, a finding with potential relevance to cigarette smoke-induced lung injury.
Ceramides are upregulated in the lungs of patients with severe emphysema, as well as in lungs from mice and rats treated with VEGF receptor 2 inhibitors, a model of apoptosis-dependent emphysema (27, 28) . We report here the novel finding that cigarette smoke increases ceramides in the lungs of mice after 4 wk of intermittent exposure (5 h a day, 5 days a wk). This timepoint precedes the development of morphological changes of emphysema that typically occur after 4 -6 mo of exposure in DBA2 or C57/Bl6 mice, respectively (3). It remains to be determined the role of ceramide to the contribution of concomitant inflammation, oxidative stress, apoptosis, and extracellular matrix remodeling in the setting of cigarette smoking. To address the direct effects of increased lung ceramide levels, we augmented ceramide levels via instillation of bioactive ceramide and noted that it triggered oxidative stress, apoptosis, macrophage influx in the lung parenchyma, and activation of extracellular matrix proteases MMP-12 (28) , and, as shown in the present studies, MMP-9. While many of these findings recapitulate phenotypically the chronic manifestations of experimental emphysema, other changes, including the extent and reversibility of the extracellular matrix degradation, remain to be determined. Notwithstanding these potential limitations, our experimental approach based on intratracheal delivery of ceramide in the lung allowed us to link ceramidespecific signaling mechanisms and redox balance in the lung. In line with our findings, overexpression of Cu/Zn SOD resulted in protection against cigarette smoke-induced air space enlargement in mice (12) . It is therefore conceivable that ceramide might participate in the generation of oxidative stress via generation of superoxide, thus contributing to cigarette smoke-induced lung injury.
The inability of the transgenic Cu/Zn SOD mouse to augment the ASMase activity from its baseline in response to exogenous ceramide may imply that Cu/Zn SOD exerted its protective effects by limiting the amplification of ceramide synthesis in the ceramide-challenged lung. Furthermore, these findings indicate a redox-dependent regulation of lung ASMase activity. Such an effect, first reported by Lavrentiadou et al. (22) who noted that in A549 cells glutathione modulated hydrogen peroxide-induced ASMase activity, was recently confirmed in endothelial cells (47) . There is growing evidence that ASMase mediates cellular injury in the liver (21) and inflammatory effects in the lung induced by platelet-activating factor or Pseudomonas infection (14) . Similar to our previous report (28) , ceramide instillation increased lung ASMase activity in wild-type mice. Future studies will determine whether cigarette smoke initiates a similar mechanism of ROS-dependent ASMase upregulation and amplification of (paracellular) ceramide synthesis in the lung, similar to our finding of extraor paracellular pools of ceramide contributing to alveolar cell apoptosis in the VEGF receptor blockade model (28) .
The prooxidative impact of ceramides in the lung may stem from a direct effect on mitochondrial electron transport chain and/or an inhibitory effect on lung antioxidant enzymes (16, 17, 22, 31) . Enhanced ceramide concentrations in the lung were sufficient to increase superoxide (O 2 Ϫ ) release as a critical step in ceramide-induced lung apoptosis and alveolar enlargement. Since the protection conferred by Cu/Zn SOD overexpression was complete in the majority of animals studied, and the inhibitory effect of ceramide on catalase was not robust, we speculate that the excess in hydrogen peroxide (H 2 O 2 ) was rapidly neutralized by either catalases or glutathione peroxidases in the transgenic model. Whereas ceramide's effect on mitochondria and antioxidant catalases may be related to apoptotic activities as previously shown (16) and as suggested in our data, its inhibitory effect on the cytosolic antioxidant SOD was caspase independent. The human genome expresses three SOD genes: the cytosolic Cu/Zn SOD (SOD1), the mitochondrial Mn SOD (SOD2), and the extracellular SOD3 (19) . Transgenic mice overexpressing either Mn SOD or Cu/Zn SOD, when exposed to oxidative stress such as hyperoxia, show increased survival and decreased lung injury (43, 44) , suggesting efficient superoxide scavenging in the lungs of these animals. We focused on Cu/Zn SOD for several reasons. First, cytosolic, rather than mitochondrial, levels of SOD activity were primarily affected by ceramide augmentation in the lung. Second, Foronjy et al. (12) reported remarkable protective effect of Cu/Zn SOD overexpression on cigarette smoke-induced inflammatory markers and air space enlargement in mice. Utilizing a similar transgenic model of human Cu/Zn SOD to increase the mouse lung SOD activity to more than twice normal levels was sufficient to attenuate the oxidative stress induced by ceramides and its downstream deleterious effects on caspase-3 activation and air space enlargement. For unclear reasons, which may reflect events at the lung developmental stage, we and others (12) noted a statistically insignificant higher mean linear intercept in the control Cu/Zn SOD transgenic mice compared with untreated wild-type littermates. Overall, the significant protective effects of Cu/Zn SOD do not rule out the potential effectiveness of increasing the activity of other SODs to prevent ceramide-induced lung injury.
The mechanism by which ceramide (Cer 12:0 or Cer 8:0 ) decreased Cu/Zn SOD activity in the lung is not clear. This effect may be organ or ceramide-species specific, as in cultured neurons ceramide Cer 2:0 was found to increase Cu/Zn SOD activity (4) . Similar to our study in which lungs of Cu/Zn SOD Fig. 7 . Lung ceramide levels in response to cigarette smoke exposure in mice. A: levels of endogenous ceramides measured by tandem mass spectrometry and normalized by lipid phosphorus in lungs of mice exposed to air (n ϭ 5) or cigarette smoke (Csk; n ϭ 5) for 4 wk (means Ϯ SE; *P ϭ 0.01). B: levels of endogenous dihydroceramides, immediate precursors of ceramides in the de novo synthetic pathway, measured by tandem mass spectrometry and normalized by lipid phosphorus in the lungs of mice exposed to air or Csk for 4 wk (means Ϯ SE; *P ϭ 0.003). Fig. 6 . Effect of Cu/Zn SOD overexpression on acid sphingomyelinase (ASM) activation in ceramide-treated mice. ASM activity was measured in wild-type mice (WT) or Cu/Zn SOD transgenic (Tg) mice 48 h after intratracheal ceramide instillation utilizing a fluorometric activity assay. The enzymatic activity was normalized by protein concentration, and results were expressed as average % change compared with the vehicle control for each genotype (% ϩSE; *P ϭ 0.01, Student's t-test). Number of animals studied: Wt ϩ Veh, n ϭ 5; Wt ϩ Cer, n ϭ 4; Tg ϩ Veh, n ϭ 5; Tg ϩ Cer, n ϭ 8.
transgenic animals were protected from ceramide-induced apoptosis, isolated neurons (4) or carotid arteries (9) from these transgenic mice were protected from ceramide-induced cell death or endothelial dysfunction, respectively. Interestingly, Mn SOD was found to be transcriptionally activated by ceramide in several cell lines, and it also had a protective role against ceramide-induced apoptosis (26) . While we could detect no significant effect of ceramide on the mitochondrial SOD, cotreatment with a general caspase inhibitor did increase its activity. While establishing the mechanism of this increase was beyond the scope of this report, we speculate the Mn SOD could have been activated by a potential increase in ROS triggered by caspase inhibition. Indeed, caspase inhibition with ZVAD-fmk has been shown to stimulate ROS accumulation via autophagic-induced catalase degradation (46) . It is therefore possible that ZVAD treatment increased ROS causing a stimulation of Mn SOD activity, whereas the Cu/Zn SOD and catalase activities were not increased due to a direct suppression from ceramide and ZVAD, respectively.
Numerous reports have implicated excessive levels of oxidative stress in the pathogenesis of emphysema, usually attributed to cigarette smoke or phagocyte activation (5, 25) . Erythrocytes and alveolar macrophages from smokers show altered activities of the antioxidant enzymes, which are hypothesized to be initially activated, but eventually overwhelmed, in their ability to scavenge the excess free radicals (25, 45) . ROS are well known to play various roles in the cellular stress responses, from physiological intracellular signaling, to injury and cell death. The type of cell death induced by oxidative stress depends on the cell type and amounts of ROS released. Classically, high levels of ROS are associated with necrosis, whereas moderate to low levels of ROS cause apoptosis (23) . More recently, apoptosis itself has been incriminated in further augmentation of the oxidant stress (42) , presumed through the activation of mitochondrial sources of ROS, or through secondary necrosis, although the precise mechanisms are yet to be elucidated. The findings of our study support the notion that excessive oxidative stress and apoptosis mutually interact and contribute to alveolar space enlargement.
In conclusion, ceramide upregulation in the lung increased oxidative stress and apoptosis, whereas preservation of antioxidant defenses, particularly of Cu/Zn SOD, inhibited caspase activation and interrupted the activation of acid sphingomyelinase and thus potentially the endogenous upregulation of ceramide. These observations may be pertinent to human emphysema, where pathogenic positive feedback loops such as those between oxidative stress and apoptosis may explain the relentless progression of alveolar destruction, even after patients abstain from smoking.
